CIK 0001725160
- Non-accelerated filer
- Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823607803
- Phone
- +1 858-263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- 4 Open-market sale Chief Operating Officer sold 10,000 shares at an average $46.94 ($469,374)
- 4 Open-market sale Director sold 10,000 shares at an average $44.94 ($449,387)
- 4 Open-market sale President & CEO sold 20,942 shares at an average $49.98 ($1,046,649)
- 4 Open-market sale Chief Operating Officer sold 10,000 shares at an average $49.09 ($490,933)
- 4 Open-market sale Chief Financial Officer sold 1,913 shares at an average $49.10 ($93,921)
- 4 Open-market sale Director sold 10,000 shares at an average $51.93 ($519,295)
- 4 Open-market sale Chief Operating Officer sold 14,688 shares at an average $52.47 ($770,633)
- 4 Open-market sale SVP, Clinical Development sold 601 shares at an average $50.23 ($30,188)
- 4 Open-market sale Chief Legal Officer sold 691 shares at an average $50.23 ($34,708)
- 4 Grant or award Chief Financial Officer acquired 16,405 shares (grant or award)
- 4 Open-market sale Director sold 7,188 shares at an average $50.19 ($360,775)
- 4 Open-market sale President & CEO sold 4,733 shares at an average $50.23 ($237,733)
- 4 Open-market sale Director sold 10,000 shares at an average $53.45 ($534,474)
- 4 Open-market sale President & CEO sold 20,942 shares at an average $57.77 ($1,209,892)
- 4 Open-market sale SVP, Clinical Development sold 30,000 shares at an average $61.36 ($1,840,745)
- 4 Open-market sale Chief Operating Officer sold 10,000 shares at an average $59.99 ($599,912)
- 4 Open-market sale Director sold 10,000 shares at an average $62.64 ($626,376)
- 4 Open-market sale Chief Operating Officer sold 10,000 shares at an average $68.41 ($684,097)
- 4 Open-market sale President & CEO sold 20,942 shares at an average $79.38 ($1,662,308)
- 4 Open-market sale Director sold 1,000 shares at $83.74 ($83,740)
Page 7 of 13 · 252 filings